申请人:Eli Lilly and Company
公开号:US20200290997A1
公开(公告)日:2020-09-17
The invention provides BTK Inhibitor compounds, pharmaceutically acceptable salts, pharmaceutical compositions thereof, and methods of using these compounds, salts, or compositions to treat autoimmune diseases such as Rheumatoid Arthritis.